ZidiBlog

Gene therapy maker Sarepta tells FDA it won’t halt shipments despite patient deaths - AP News

WASHINGTON (AP) Drugmaker Sarepta Therapeutics said late Friday it wont comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy following the death of a …

Mapped: English Proficiency Around the World - Visual Capitalist

United Airlines to expand 'undersized' Premium Plus cabin - The Points Guy

United Airlines is doubling down on premium economy Over the coming years, travelers can expect to see the Chicago-based carrier's Premium Plus cabin expand, with more seats. And more redemption opp…

Smart Investor: Best Dividend Stocks to Buy, Where’s the Broadening and Headline Fatigue - Morningstar

Want to stay informed with market insights and investing ideas from Morningstar? Sign up for my weekly Smart Investor newsletter here. This weeks highlights: There was lots of news this week, but y…

Why cheaper power looks unlikely as Trump’s big budget law reshuffles the U.S. energy landscape - MarketWatch

President Donald Trumps signature One Big Beautiful Bill Act, which became law earlier this month, is likely to change the nations energy landscape potentially leading to higher power costs just as t…

How Three Friends Built a Multimillion-Dollar Brand by Making Sunscreen Fun Again - The Wall Street Journal

Dollar gets reprieve as US economy shrugs off tariffs - Financial Times

Complete digital access to quality analysis and expert insights, complemented with our award-winning Weekend Print edition. Everything in PrintWeekday Print EditionFT …

3 reasons why investors have largely ignored Trump’s tariff threats as Aug. 1 deadline approaches - MarketWatch

Investors over the past few weeks have countenanced a barrage of tariff threats as the Trump administration has ratcheted up the pressure on U.S. trade partners ahead of its Aug. 1 deal deadline. A…